Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Bacterial Infections
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Bacterial Infections
    Methicillin-Resistant Staphylococcus aureus Strain Linked to High Mortality Rates: Presented at IDSA - (DGDispatch)
    Study Examines Associations Between Antibiotic Use During Pregnancy, Birth Defects - (DGNews)
    Using Linezolid Instead of Vancomycin to Treat Serious Infections Means Fewer Rehospitalisations: Presented at IDSA - (DGDispatch)
    Rifaximin Alleviates Symptoms Due to Small Intestine Bacterial Overgrowth: Presented at ACG - (DGDispatch)
    TopAbstracts in Bacterial Infections 10/26/2009 - (DGNews)

    News archive

     Recent webcasts/CME - Bacterial Infections
      Drug-Resistant TB
      Peritoneal Tuberculosis: Modern Peril for an Ancient Disease
      Infectious Complications of Biologic Therapies: Preventive and Therapeutic Strategies
      Relative Risks of Serious Bacterial and Opportunistic Infections Among Biologics: Results of Randomized Trials and Observational Studies
      Importance of Assessing Immunocompetence in Biologic Drug Development

      Webcasts/CME archive

       Recent cases - Bacterial Infections
        A 72-Year-Old Man with a Rapidly Progressive Sepsis Caused by a Rare But Life-Threatening Infection
        A Rare Case of Cervical Tuberculosis Simulating Carcinoma Cervix: A Case Report
        Primary Tubercular Liver Abscess in an Immunocompetent Adult: A Case Report
        Bordetella Bronchiseptica Pneumonia in a Man with Acquired Immunodeficiency Syndrome: A Case Report
        Clostridium Septicum Sepsis and Colorectal Cancer - A Reminder

        Cases archive
          




        my personal edition > bacterial infections > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Linezolid Fails In Dialysis Patient With Enterococcal Endocarditis

        A DGReview of :"Failure of Linezolid Treatment for Enterococcal Endocarditis"
        Clinical Infectious Diseases

        09/16/2003
        By Emma Hitt, PhD


        A case report describing linezolid failure in a dialysis patient with enterococcal endocarditis may be the first reported clinical failure of linezolid in a patient with a drug-susceptible Enterococcus faecalis infection.

        Linezolid is the first oxalidinone antibiotic approved for clinical use. It is approved for treatment of pneumonia and skin and soft-tissue infections and has activity against Staphylococcus aureus, E. faecalis, Enterococcus faecium, and Streptococcus pneumoniae, note Shanta M. Zimmer, MD, with Emory University, Atlanta, Georgia, United States, and colleagues.

        Although linezolid has shown promise against drug-resistant enterococcal species and vancomycin-resistant E. faecium endocarditis, its effectiveness in patients infected with these organisms has not been well studied.

        The report describes a 40-year-old man with end-stage renal disease who was admitted to the hospital because of fevers and chills occurring during haemodialysis.

        Eight weeks previously, the patient had been treated for group B streptococcal endocarditis of the aortic valve. Treatment with ampicillin was changed to levofloxacin because of allergic response, and the patient completed a total of 6 weeks of therapy. Follow-up blood cultures were negative.

        Upon readmission to the hospital, blood samples were positive for E. faecalis susceptible to vancomycin, ampicillin, streptomycin, and linezolid but resistant to levofloxacin and gentamicin.

        The patient received 600 mg of intravenous linezolid every 12 hours but developed worsening congestive heart failure in the third week of his hospitalisation. Cultures of blood remained positive for E. faecalis. However, after more than 2 weeks of linezolid therapy, testing revealed continued sensitivity with a minimum inhibitory concentration of 2 mcg/mL.

        The patient was treated with 2 grams of ampicillin every 12 hours and 1 gram of streptomycin after each session of haemodialysis, and bacteraemia cleared within 24 hours of ampicillin therapy. He also underwent replacement of the mitral and aortic valves, which were necrotic without discreet vegetations, as well as repair of the tricuspid valve leaflet, from which a vegetation was excised.

        After 6 weeks of intravenous therapy with ampicillin and streptomycin following surgery, the patient was healthy 6 months later.

        "Linezolid therapy failed in our patient's case, not because of resistance, but presumably because of a combination of host factors and antibiotic failure related to the organisms sequestered within his valvular vegetation," they conclude.

        Clinical Infectious Diseases 2003;37:e29-e30. "Failure of Linezolid Treatment for Enterococcal Endocarditis"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send